Mid-Atlantic Biomanufacturing Scale-Up Cluster (MABSC)
Building the Mid-Atlantic’s path from pilot scale to domestic biomanufacturing.
From Pilot to Production
The science works. The gap is getting it made.
Too many U.S.-developed therapies, devices and diagnostics stall before they reach qualified, domestic, commercial-scale manufacturing. Small companies can’t easily see what readiness requires. Quality expertise is fragmented and expensive, buyers are hard to reach, and capital funds trials and clearances, not production.
On the other side, the region’s manufacturers, suppliers and investors want domestic partners but find small companies costly to discover, vet and qualify one at a time.
MABSC is a single front door for both: a U.S. Small Business Administration Regional Innovation Cluster led by the Science Center. Emerging companies can join from anywhere in the country, and the network of suppliers, service providers, manufacturers, investors and technical partners they join is rooted in PA, NJ, DE, MD and DC.
Find your path
For Emerging Companies
Your product works. Now let’s get it made, here.
You get a free, one-on-one path from bench or prototype to qualified U.S. production. You’ll know where you stand on manufacturing readiness and have a plan you can actually execute. You’ll also meet the manufacturers, CDMOs and health systems who can get you there, and you won’t give up any equity.
Benefits
- Know where you stand. You get a readiness scorecard across cGMP, QMS and ISO, plus a dedicated mentor.
- Pressure-test before you spend. An independent technical review checks scale-up feasibility and your quality system before you commit capital.
- Meet the people who decide. You’ll get warm introductions to corridor manufacturers, CDMOs and health systems, SBIR/STTR proposal support, and a seat at the annual capital readiness capstone.
- Rolling intake. Move at your own pace, set by milestones rather than the calendar.
Building a device or diagnostic? Get hands-on help with design transfer, ISO 13485 and QMSR alignment, and choosing a contract manufacturer.
For Mid-Atlantic Partners
Companies are coming here to scale. Be who they scale with.
You get a steady pipeline of prepared companies from across the country. Each one has already been assessed, is working from a manufacturing roadmap, and is looking for exactly what the region makes, supplies, tests and finances. You won’t have to run national outreach to find them, and you’ll have the outcome data to show results. Partnership is free, and the commitment is light.
Benefits
- Meet prepared companies, not cold leads. Every company arrives with a readiness scorecard and an independently reviewed plan, so you spend less time scoping, vetting and qualifying.
- Shape what they’re ready for. Tell us what your audits, facilities or investment criteria require, and CRP-BIO prepares companies to meet it.
- Get seen and get credit. You get visibility through the MidAtlantic Biomanufacturing Asset Directory and cluster convenings, plus aggregate outcomes you can count in your own reporting.
We're seeking partners who are based or operate in PA, NJ, DE, MD or DC: Suppliers and service providers, manufacturers and health systems, investors and lenders, technical and facility partners, and the organizations that refer founders to us. Suppliers and service providers also get free one-on-one support to become qualified domestic sources.
What the cluster is building for the nation
CRP-BIO
A version of our Capital Readiness Program built for manufacturing scale-up. You get a readiness scorecard, a manufacturing roadmap, independent technical validation, buyer introductions and SBIR/STTR support, all one-on-one.
Mid-Atlantic Biomanufacturing Asset Directory
A guide to the region’s suppliers, service providers, facilities and expertise, updated quarterly. Every listing is equal, and there’s no paid placement.
The Cluster Network
This includes buyer-requirements sessions, convenings, and an annual capital readiness capstone with investors who advise but never select. Free. Neutral. No equity, no fees, no paid placement.